Which of the following statements about neuromuscular blocking agents is false?
Select Your Answer:
The actions of nondepolarizing blocking agents are readily reversed by increasing the concentration of normal transmitters at the receptors.
Reversal of nondepolarizing drugs is best accomplished by administering choline esterase inhibitors such as neostigmine.
In contrast, the paralysis produced by depolarizing blockers is increased by cholinesterase inhibitors.
The drugs block neuromuscular transmission at the neuromuscular junction causing paralysis of the skeletal muscles. This is accomplished either by acting presynaptically via the inhibition of acetylcholine synthesis or release or by acting postsynaptically at the acetylcholine receptors of the motor nerve end-plate. In clinical use, neuromuscular blockade is used adjunctively to anesthesia to paralyze the vocal cords and permit intubation of the trachea as well as to optimize the surgical field by inhibiting spontaneous ventilation to cause relaxation of skeletal muscles. Because the appropriate dose of neuromuscular-blocking drug may paralyze the muscles of the diaphragm, mechanical ventilation should be available. Patients are still aware of pain; hence, general anesthetics or analgesics must also be given.
Murray MJ,Brull SJ,Bolton CF, Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2006 Nov [PubMed PMID: 17079642]
Waud BE,Waud DR, Interaction of calcium and potassium with neuromuscular blocking agents. British journal of anaesthesia. 1980 Sep [PubMed PMID: 7437224]
Agoston S,Vandenbrom RH,Wierda JM, Clinical pharmacokinetics of neuromuscular blocking drugs. Clinical pharmacokinetics. 1992 Feb [PubMed PMID: 1551294]
Srivastava A,Hunter JM, Reversal of neuromuscular block. British journal of anaesthesia. 2009 Jul [PubMed PMID: 19468024]
Naguib M,Kopman AF,Lien CA,Hunter JM,Lopez A,Brull SJ, A survey of current management of neuromuscular block in the United States and Europe. Anesthesia and analgesia. 2010 Jul [PubMed PMID: 19910616]
Prabhakar A,Kaye AD,Wyche MQ,Salinas OJ,Mancuso K,Urman RD, Novel drug development for neuromuscular blockade. Journal of anaesthesiology, clinical pharmacology. 2016 Jul-Sep [PubMed PMID: 27625489]
Messieha ZS,Guirguis S,Hanna S, Bispectral index monitoring (BIS) as a guide for intubation without neuromuscular blockade in office-based pediatric general anesthesia: a retrospective evaluation. Anesthesia progress. 2011 Spring [PubMed PMID: 21410358]
Short TG,Campbell D,Leslie K, Response of bispectral index to neuromuscular block in awake volunteers. British journal of anaesthesia. 2016 May [PubMed PMID: 27106988]
Schuller PJ,Newell S,Strickland PA,Barry JJ, Response of bispectral index to neuromuscular block in awake volunteers. British journal of anaesthesia. 2015 Jul [PubMed PMID: 26174308]
Messner M,Beese U,Romstöck J,Dinkel M,Tschaikowsky K, The bispectral index declines during neuromuscular block in fully awake persons. Anesthesia and analgesia. 2003 Aug [PubMed PMID: 12873942]
Bom A,Bradley M,Cameron K,Clark JK,Van Egmond J,Feilden H,MacLean EJ,Muir AW,Palin R,Rees DC,Zhang MQ, A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angewandte Chemie (International ed. in English). 2002 Jan 18 [PubMed PMID: 12491405]
Pühringer FK,Rex C,Sielenkämper AW,Claudius C,Larsen PB,Prins ME,Eikermann M,Khuenl-Brady KS, Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. 2008 Aug [PubMed PMID: 18648227]
de Boer HD,Driessen JJ,Marcus MA,Kerkkamp H,Heeringa M,Klimek M, Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology. 2007 Aug [PubMed PMID: 17667567]
Groudine SB,Soto R,Lien C,Drover D,Roberts K, A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesthesia and analgesia. 2007 Mar [PubMed PMID: 17312208]
Barrio J,Errando CL,García-Ramón J,Sellés R,San Miguel G,Gallego J, Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: A randomized blinded study. Journal of clinical anesthesia. 2017 Nov [PubMed PMID: 28803124]
Martini CH,Boon M,Bevers RF,Aarts LP,Dahan A, Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. British journal of anaesthesia. 2014 Mar [PubMed PMID: 24240315]
Boon M,Martini CH,Aarts LP,Bevers RF,Dahan A, Effect of variations in depth of neuromuscular blockade on rating of surgical conditions by surgeon and anesthesiologist in patients undergoing laparoscopic renal or prostatic surgery (BLISS trial): study protocol for a randomized controlled trial. Trials. 2013 Mar 1 [PubMed PMID: 23452344]